Showing results (41-50 of 109) with videos related to
Sort By:
Pageof 11
Journal of Chemical Information and Modeling|July 2, 2024
Proximity Graph Networks: Predicting Ligand Affinity with Message Passing Neural NetworksZachary J Gale-Day, Laura Shub, Kangway V Chuang, et al.Nature Chemical Biology|June 2, 2009
Quantifying biogenic bias in screening librariesJérôme Hert, John J Irwin, Christian Laggner, et al.Journal of Chemical Information and Modeling|February 5, 2025
Fuzz Testing Molecular Representation Using Deep Variational Anomaly GenerationVictor H R Nogueira, Rishabh Sharma, Rafael V C Guido, et al.Journal of Chemical Information and Modeling|December 2, 2017
Predicted Biological Activity of Purchasable Chemical SpaceJohn J Irwin, Garrett Gaskins, Teague Sterling, et al.Psychopharmacology Bulletin|June 29, 2010
A pilot study of the pharmacodynamic impact of SSRI drug selection and beta-1 receptor genotype (ADRB1) on cardiac vital signs in depressed patients: a novel pharmacogenetic approachKelan L H Thomas, Vicki L Ellingrod, Jeffrey R Bishop, et al.The Journal of Investigative Dermatology|April 2, 2020
Artificial Intelligence in Dermatology: A PrimerAlbert T Young, Mulin Xiong, Jacob Pfau, et al.Scientific Reports|August 31, 2025
C-terminal fusion partner activity contributes to the oncogenic functions of YAP1::TFE3Patrick J Cimino, Dylan J Keiser, Abigail G Parrish, et al.The Journal of Laboratory and Clinical Medicine|February 1, 1981
Multiple short-term effects of lead on the renin-angiotensin systemJ M Goldman, A J Vander, D R Mouw, et al.Biorxiv : the Preprint Server for Biology|June 12, 2025
An improved model for prediction of de novo designed proteins with diverse geometriesBenjamin Orr, Stephanie E Crilly, Deniz Akpinaroglu, et al.Biorxiv : the Preprint Server for Biology|April 28, 2025
C-terminal fusion partner activity contributes to the oncogenic functions of YAP1::TFE3Patrick J Cimino, Dylan J Keiser, Abigail G Parrish, et al.Pageof 11